NO874904L - Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser. - Google Patents

Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser.

Info

Publication number
NO874904L
NO874904L NO874904A NO874904A NO874904L NO 874904 L NO874904 L NO 874904L NO 874904 A NO874904 A NO 874904A NO 874904 A NO874904 A NO 874904A NO 874904 L NO874904 L NO 874904L
Authority
NO
Norway
Prior art keywords
alkyl
methyl
hydroxy
compound
nujol
Prior art date
Application number
NO874904A
Other languages
English (en)
Norwegian (no)
Other versions
NO874904D0 (no
Inventor
Youichi Shiokawa
Masanobu Nagano
Hiromichi Itani
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628262A external-priority patent/GB8628262D0/en
Priority claimed from GB878723439A external-priority patent/GB8723439D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO874904D0 publication Critical patent/NO874904D0/no
Publication of NO874904L publication Critical patent/NO874904L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO874904A 1986-11-26 1987-11-25 Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser. NO874904L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628262A GB8628262D0 (en) 1986-11-26 1986-11-26 Imidazopyridine compounds
GB878723439A GB8723439D0 (en) 1987-10-06 1987-10-06 Imidazopyridine compounds

Publications (2)

Publication Number Publication Date
NO874904D0 NO874904D0 (no) 1987-11-25
NO874904L true NO874904L (no) 1988-05-27

Family

ID=26291587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874904A NO874904L (no) 1986-11-26 1987-11-25 Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser.

Country Status (13)

Country Link
US (1) US4831041A (OSRAM)
EP (1) EP0268989B1 (OSRAM)
KR (1) KR880006237A (OSRAM)
CN (1) CN87108027A (OSRAM)
AU (1) AU8169387A (OSRAM)
DE (1) DE3780263T2 (OSRAM)
DK (1) DK608887A (OSRAM)
ES (1) ES2064310T3 (OSRAM)
FI (1) FI875157A7 (OSRAM)
GR (1) GR3005685T3 (OSRAM)
HU (1) HUT45526A (OSRAM)
IL (1) IL84522A0 (OSRAM)
NO (1) NO874904L (OSRAM)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
AU615666B2 (en) * 1987-07-16 1991-10-10 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazols
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
DK0471236T3 (da) * 1990-07-30 1995-07-24 Takeda Chemical Industries Ltd Imidazopyridinderivater og deres anvendelse
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
GB9201693D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
ATE215084T1 (de) * 1994-07-28 2002-04-15 Byk Gulden Lomberg Chem Fab Imidazopyridin-azolidinone
WO1996003403A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridine
CA2196075A1 (en) * 1994-07-28 1996-02-08 Gerhard Grundler Halogenated imidazopyridines
EP0882048B1 (de) * 1996-01-26 2005-05-04 ALTANA Pharma AG 3-alkylimidazopyridine
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
DK1861074T3 (da) * 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
ES2790358T3 (es) 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
EP3141542B1 (en) * 2011-12-28 2020-05-27 Global Blood Therapeutics, Inc. Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CA2903022C (en) 2013-03-15 2021-11-09 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA034922B1 (ru) 2013-03-15 2020-04-07 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
SG11201507453VA (en) 2013-03-15 2015-10-29 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SG11201510135XA (en) 2014-02-07 2016-01-28 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
TW201731509A (zh) 2015-12-04 2017-09-16 全球血液治療公司 針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
AU8169387A (en) 1988-06-02
CN87108027A (zh) 1988-06-08
HUT45526A (en) 1988-07-28
FI875157A0 (fi) 1987-11-23
KR880006237A (ko) 1988-07-22
ES2064310T3 (es) 1995-02-01
DK608887A (da) 1988-05-27
US4831041A (en) 1989-05-16
FI875157A7 (fi) 1988-05-27
DE3780263T2 (de) 1992-12-24
NO874904D0 (no) 1987-11-25
IL84522A0 (en) 1988-04-29
DK608887D0 (da) 1987-11-19
EP0268989A1 (en) 1988-06-01
DE3780263D1 (de) 1992-08-13
GR3005685T3 (OSRAM) 1993-06-07
EP0268989B1 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
US4831041A (en) Imidazopyridine compounds and processes for preparation thereof
US4920129A (en) Anti-ulcerative imidazopyridine compounds
JP2848230B2 (ja) 三環式化合物
US6316482B1 (en) Benzamide derivatives having a vasopressin antagonistic activity
JP2763036B2 (ja) 複素環化合物
EP0770079B1 (en) Heterobicyclic derivatives
US4698349A (en) Quinolizinone compounds, and pharmaceutical composition comprising the same, useful as anti-ulcerative and anti-allergic agents
JPH11505524A (ja) イミダゾ1,2−aピリジンおよびイミダゾ1,2−aピリデジン誘導体、および骨吸収阻害剤としてのその用途
EP0531901A2 (en) Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity
WO1992012154A1 (en) Imidazotriazine derivatives
US5750699A (en) Method of preparing certain 3-halo-imidazopyridines
KR20010094731A (ko) 이미다졸 화합물 및 그의 의약 용도
JPH1087629A (ja) 新規イソキノリン誘導体、およびその医薬用途
IE911641A1 (en) Indole derivatives
EP0874845B1 (en) Pyrido (2,3-b) pyrazine derivatives
US4831030A (en) Diphenylpyridine compounds, processes for the preparation thereof and composition comprising the same
KR880001411B1 (ko) 세펨화합물의 제조방법
EP0436157B1 (en) Quinazoline derivatives and their preparation
US4738967A (en) Imidazoisoquinoline compounds useful as anti-ulcerative agents
JP3135917B2 (ja) 血小板活性化因子拮抗剤
JPH05222000A (ja) ベンズイミダゾール誘導体およびその製造方法
JPH05213971A (ja) 新規セフェム化合物
WO2003045950A1 (en) Pyrazolopyridine derivtives and their pharmaceutical use
JPH11508588A (ja) キナゾリン誘導体
JPS63146881A (ja) イミダゾピリジン化合物およびその製造法